Synthetic modification of protein surfaces to mediate induced-proximity pharmacology
RSC Medicinal Chemistry · 2024 · 15 (9) · 2974-2979
DOI: 10.1039/d4md00388h ↗Kurz gefasst
Editorial in der Zeitschrift RSC Medicinal Chemistry, 2024. Verfasst von Lyn H Jones. Beteiligte Einrichtung: Center for Protein Degradation, Dana-Farber Cancer Institute 360 Longwood Avenue Boston MA USA. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Ligand-directed site-specific covalent modification of protein surfaces will advance synthetic re-wiring of biological pathways.
Autor:innen und Institutionen
- Center for Protein Degradation, Dana-Farber Cancer Institute 360 Longwood Avenue Boston MA USA.
- Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School Boston MA USA lyn_jones@dfci.harvard.edu.
ORCID-Profile: Lyn H Jones
Zitieren
APA
Jones, L. H. (2024). Synthetic modification of protein surfaces to mediate induced-proximity pharmacology. RSC Medicinal Chemistry, 15(9), 2974-2979. https://doi.org/10.1039/d4md00388h
Vancouver
Jones LH. Synthetic modification of protein surfaces to mediate induced-proximity pharmacology. RSC Medicinal Chemistry. 2024;15(9):2974-2979. doi:10.1039/d4md00388h
BibTeX
@article{Jones2024,
author = {Jones, Lyn H},
title = {Synthetic modification of protein surfaces to mediate induced-proximity pharmacology},
journal = {RSC Medicinal Chemistry},
year = {2024},
volume = {15},
number = {9},
pages = {2974--2979},
doi = {10.1039/d4md00388h}
}
EUVIMED